Loading [Contrib]/a11y/accessibility-menu.js

Canadian Chronic Disease Surveillance System (CCDSS)

Select item(s) from each list below:




Optional:



Chart: Stroke, age-standardized incidence rate, per 100,000, age 20 years and older, CanadaTabular data available lower on summary table.01002003004005002003–20042004–20052005–20062006–20072007–20082008–20092009–20102010–20112011–20122012–20132013–20142014–20152015–20162016–20172017–20182018–20192019–20202020–2021*2021–2022*2022–2023*Both sexesMalesFemalesCOVID-19 Pandemic Source: Canadian Chronic Disease Surveillance System data files provided by provinces and territories, as of July 2024.Public Health Agency of Canada, Health Infobase https://health-infobase.canada.caReset ZoomReset Zoom

For more information on the interpretation of the data please see the notes below.

Summary Table: Stroke, age-standardized incidence rate, per 100,000, age 20 years and older, Canada
Sex
Fiscal year
Rate (per 100,000)
95% CI
CV (%)
Counts
Flag
Both sexes
2003–2004
381
379–384
0.35
80,995
0
Both sexes
2004–2005
374
371–376
0.35
81,405
0
Both sexes
2005–2006
362
359–364
0.35
80,840
0
Both sexes
2006–2007
344
341–346
0.36
78,685
0
Both sexes
2007–2008
334
331–336
0.36
78,365
0
Both sexes
2008–2009
327
325–329
0.35
79,680
0
Both sexes
2009–2010
322
320–324
0.35
80,700
0
Both sexes
2010–2011
312
310–314
0.35
80,380
0
Both sexes
2011–2012
305
302–307
0.35
80,720
0
Both sexes
2012–2013
297
295–299
0.35
80,990
0
Both sexes
2013–2014
293
291–295
0.35
82,220
0
Both sexes
2014–2015
299
297–301
0.34
85,865
0
Both sexes
2015–2016
298
296–300
0.34
87,470
0
Both sexes
2016–2017
294
292–296
0.34
88,935
0
Both sexes
2017–2018
288
286–290
0.34
89,630
0
Both sexes
2018–2019
285
283–286
0.33
90,840
0
Both sexes
2019–2020
279
277–281
0.33
91,770
0
Both sexes
2020–2021*
269
267–271
0.34
90,205
0
Both sexes
2021–2022*
276
275–278
0.33
93,080
0
Both sexes
2022–2023*
274
272–276
0.33
94,985
0
Males
2003–2004
427
423–431
0.52
38,860
0
Males
2004–2005
418
413–422
0.52
39,200
0
Males
2005–2006
402
398–406
0.52
38,960
0
Males
2006–2007
385
381–389
0.52
38,390
0
Males
2007–2008
372
369–376
0.52
38,250
0
Males
2008–2009
366
363–370
0.51
39,230
0
Males
2009–2010
356
352–360
0.51
39,315
0
Males
2010–2011
346
342–349
0.51
39,495
0
Males
2011–2012
336
333–340
0.51
39,765
0
Males
2012–2013
329
326–333
0.50
40,275
0
Males
2013–2014
325
322–328
0.50
41,040
0
Males
2014–2015
331
328–334
0.49
42,870
0
Males
2015–2016
332
329–335
0.48
44,175
0
Males
2016–2017
327
324–330
0.48
44,945
0
Males
2017–2018
318
315–321
0.48
45,070
0
Males
2018–2019
317
314–320
0.47
46,400
0
Males
2019–2020
310
307–313
0.47
46,790
0
Males
2020–2021*
299
296–301
0.47
46,125
0
Males
2021–2022*
306
303–309
0.46
47,545
0
Males
2022–2023*
305
302–308
0.46
48,845
0
Females
2003–2004
345
342–348
0.49
42,130
0
Females
2004–2005
339
335–342
0.49
42,210
0
Females
2005–2006
328
325–331
0.49
41,875
0
Females
2006–2007
310
307–313
0.50
40,295
0
Females
2007–2008
301
298–304
0.50
40,115
0
Females
2008–2009
294
291–297
0.50
40,450
0
Females
2009–2010
293
291–296
0.49
41,380
0
Females
2010–2011
283
280–285
0.50
40,890
0
Females
2011–2012
277
274–279
0.50
40,955
0
Females
2012–2013
268
265–271
0.50
40,720
0
Females
2013–2014
264
262–267
0.50
41,180
0
Females
2014–2015
271
268–273
0.49
42,995
0
Females
2015–2016
268
265–270
0.49
43,295
0
Females
2016–2017
265
262–267
0.48
43,995
0
Females
2017–2018
262
259–264
0.48
44,565
0
Females
2018–2019
255
253–257
0.48
44,445
0
Females
2019–2020
251
249–254
0.48
44,985
0
Females
2020–2021*
243
240–245
0.49
44,085
0
Females
2021–2022*
250
247–252
0.48
45,535
0
Females
2022–2023*
246
244–248
0.48
46,140
0
Download Detailed Table:
Stroke, age-standardized incidence rate
Download Summary Table
Notes:
  • *Many CCDSS measures, such as chronic disease incidence, were influenced by the COVID-19 pandemic. Changes in such measures may be driven by multiple factors, including (but not limited to) differences in healthcare seeking behaviour, the availability and use of healthcare services, as well as true changes in health status. As such, CCDSS measures should be used cautiously when making inferences about population health during the COVID-19 pandemic. Guidance for data users on examining the impacts of the COVID-19 pandemic on CCDSS measures can be accessed below.
  • Data suppression: Estimates are not reported when the counts are less than 10 or the coefficient of variation is greater than 33.3%.
  • Due to periodic updates of the historical surveillance data, estimates for a particular disease and year may change over time, and may not be comparable to previous editions.
  • Estimates are age-standardized to the 2011 Canadian population using unrounded counts and five-year age groups. Age-standardized estimates are useful for comparing data across years or between different geographical areas, but they do not reflect the actual impact of the disease.
  • Nunavut data are excluded before 2005–2006.
  • Newfoundland and Labrador data are excluded before 2008–2009.
  • Yukon data are excluded before 2010–2011.
  • The modernization of the Quebec billing system for fee-for-service medical services by the Régie de l'assurance maladie du Québec (RAMQ) in 2016 has resulted in a decrease in the entry of diagnostic codes in the fee-for-service medical services file. Data for 2016–2017 and subsequent years should therefore be interpreted with caution, as a slight underestimation is suspected.
  • The introduction of the Northwest Territories Electronic Medical Record (EMR) in 2016 resulted in more complete and consistent data. Data for 2016–2017 may be slightly underestimated compared to previous years due to the system transition. 
  • New Brunswick data were not available for 2021–2022 and 2022–2023.
  • Northwest Territories data were not available for 2022–2023.
  • Northwest Territories physician claim data were incomplete for 2021–2022 and should therefore be interpreted with caution, as a slight underestimation is suspected.
Source: Canadian Chronic Disease Surveillance System 2024
Methods: CCDSS Summary of Methods
Case definitions: CCDSS Case Definitions
COVID-19 Documentation: CCDSS COVID-19 guidance for data users

Acknowledgements

These data were made possible through collaboration between PHAC and the respective provincial and territorial governments of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Northwest Territories, Yukon, and Nunavut. No endorsement by the provinces and territories is intended or should be inferred. Provincial and territorial data were contributed to the CCDSS as of July 2024.

Did you find what you were looking for?

What was wrong?

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Report a problem or mistake on this page
Date modified:
2024-10-15